8-KCorporate ChangesExhibits & Filings

CVS HEALTH Corp 8-K Report, Bylaw Amendment (Jul 10, 2020)

Filed July 10, 2020For Securities:CVS

Summary

CVS Health Corporation (CVS) has filed an 8-K report on July 10, 2020, primarily detailing amendments to its By-laws, effective immediately as of July 8, 2020. These changes are largely procedural and designed to update corporate governance mechanisms. Key revisions include modifications to advance notice provisions for director nominations and stockholder proposals, procedures for calling special meetings and acting by written consent, and clarifications on stockholder meeting conduct, including those held remotely. Furthermore, the Amended and Restated By-laws introduce provisions for special Board meetings with less than two days' notice and establish emergency by-laws. These emergency by-laws empower the Board to operate with reduced procedural requirements and take necessary actions during emergency conditions. While these changes are significant for corporate governance, they do not appear to directly impact the company's financial performance or strategic operations as of the filing date.

Key Highlights

  • 1CVS Health Corporation's Board of Directors approved amended and restated By-laws on July 8, 2020.
  • 2The amendments update and revise advance notice provisions for director nominations and stockholder proposals.
  • 3Procedures for stockholders to call special meetings and act by written consent have been revised.
  • 4Clarifications have been made regarding stockholder meeting procedures, including remote participation.
  • 5The By-laws now allow for special Board meetings with less than two days' notice.
  • 6Emergency by-laws have been added to enable the Board to operate with reduced procedural requirements during emergencies.
  • 7The filing includes the full text of the Amended and Restated By-laws as an exhibit.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and detail the amendments made to CVS Health Corporation's By-laws by its Board of Directors on July 8, 2020. These changes update and clarify various corporate governance procedures.

No, this filing does not indicate any changes to CVS Health Corporation's financial reporting practices or its fiscal year. The amendments are exclusively related to corporate governance and procedural matters.

The emergency by-laws grant the Board of Directors the authority to operate with reduced procedural requirements and take necessary actions during emergency conditions. This aims to ensure the company's continuity and operational resilience during unforeseen crises.

The by-law changes primarily affect the procedural aspects of how shareholders can nominate directors, submit proposals, and call special meetings. Investors should review the details of the advance notice provisions and meeting procedures to understand how these changes might impact their ability to influence corporate governance.